Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: A European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve
By M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefévre, H. Treede, H. Eggebrecht, P. Rubino, I. Michev, R. Lange and 2 more. Circulation, 2010
925 citations recorded by the source corpus.
Subfields: Biomaterials, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/14def16595f5171786f6c9e7e1beafd8db04e262
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- David R. Holmes
- Michael J. Mack
- Catherine M. Otto
- Vice Chair
- B. Carabello
- S. Kaul
- Chirojit Mukherjee
- D. Hildick-Smith
Citations in the corpus
- 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. (2012, background): “Incidence of major vascular complications ranges from 2% to 26% with transfemoral access and is related to vessel size, tortuosity, and degree of aortoiliac occlusive disease and from 5% to 7% with transapical access (107,109,111,116,139).”
- Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. (2011, background): “femoral cohort, is comparable to that seen in almost all studies (15,18).”